If you are an income-focused investor, and you appreciate the price appreciation potential of a good contrarian opportunity, then you may want to consider some of the ideas highlighted in this article. Specifically, we provide an overview (and data) on “Dogs of the Dow,” “Dividend Aristocrats," retail REITs, healthcare REITs, MLPs, closed end funds, and options strategies, including ten of our favorite high-yield, contrarian, blue chip opportunities right now.
Value and income investing. Long-term capital appreciation.
If you are looking for big stable growing income, Enterprise Products Partners (EPD) is worth considering. This midstream energy services provider offers an attractive 6.1% distribution yield, and the shares are on sale, in our view. Considering the company’s large and strategic footprint, stable fee-based income, vertical integration, and growth (both in assets and distributions), we have added it to our list of 10 Attractive High-Yield Blue Chips Worth Considering.
There was an interesting Warren Buffett interview last week where the “Oracle of Omaha” gave a handful of very wise advice to investors. However, we couldn’t help but notice, he seemed to make a glaring fundamental mistake. This article reviews Buffett’s good advice, postulates a couple reasons why he could have made his glaring fundamental mistake, and we finally offer a smart way (a specific security) to take advantage of Buffett’s good advice without making the same big mistake.
Interested in a Free Investment Portfolio Review?
Blue Harbinger’s Mark D. Hines works with Left Brain Wealth Management to provide custom investment advisory services to meet your individual needs. Contact us today to schedule your complimentary investment portfolio review.
Curious what your investment risk tolerance really is? Complete our 10-minute Risk Questionnaire and instantly receive your risk score.
Members-Only Investment Ideas
There’s a false narrative going around, and it has created an attractive investment opportunity in this big-dividend blue chip stock.
This report is a continuation of our free public report titled "Top 7 High-Yield Healthcare REITs Worth Considering." However, this members-only report contains the top 3...
This report is a continuation of our free public report titled "15 Attractive +7% Yields Worth Considering" except in this members-only version, we share the Top 5. We believe all five are extremely attractive high-income opportunities, and we own all 5 of the top 5.
This week's members-only investment idea is an attractive double-digit yielder. This one is a little off the beaten path, but it is highly accessible to investors, and we believe once you have read this article you'll have a better understanding of why we like it so much!
As a follow up to “part I” in this series, this “part II” article highlights more attractive healthy-dividend companies. We’re sticking with the theme that investors should NOT blindly chase after the highest yielding securities, but rather focus on those with the healthiest yields. We highlight a handful of healthy yielders including one that we own in our Blue Harbinger Disciplined Growth portfolio.
This week's investment idea is a continuation of our Blue Harbinger Weekly. Specifically, this investment idea article contains more safe big dividend ideas that we believe are attractive and worth considering.
The Blue Harbinger Weekly:
A members-only weekly report on Blue Harbinger's investments and the market.
As a follow up to our free article titled “10 Attractive High-Yield Blue Chips, For Contrarians,” this members-only article highlights five more attractive opportunities. And in this case, we currently own all five of these investments.
The Dogs of the Dow strategy proposes that an investor invests annually in the ten Dow Jones stocks with the highest dividend yield. Proponents of the strategy argue that blue-chip companies do not alter their dividend to reflect trading conditions and, therefore, the dividend is a measure of the average worth of the company. The following table ranks the 30 Dow Jones stocks by dividend yield, it includes a variety of other financial metrics, and finally we discuss two of our favorite Dogs of the Dow right now.
This week’s Weekly reviews an attractive +7% yield MLP that is on sale. We also review two growth stocks that we own in our Disciplined Growth portfolio. The MLP is very hated (and misunderstood) right now (which is why we like it), and the growth stocks have both rallied hard this year (they’re up 30% and 47%) and we share our views on how to play them going forward.
This week’s Weekly provides a brief review of every Blue Harbinger holding, including comments, year-to-date price returns and year-to-date total returns (dividends plus price appreciation). We also share market-wide data on what has been working, and what we expect will work going forward.
This week's Blue Harbinger Weekly covers a new dividend idea. Because of its size and nature, it's often overlooked. However, given its opportunity pipeline and out-sized income, we believe this one is worth considering.
The rally in Dow Jones stocks after President Trump was elected is the largest ever according to data compiled by the Wall Street Journal. However, given the sectors that have been rallying the most, and considering signals from the bond market, we believe now is an attractive time to own dividend stocks, in particular.